Your browser doesn't support javascript.
loading
Reduction of T cell receptor diversity in NOD mice prevents development of type 1 diabetes but not Sjögren's syndrome.
Kern, Joanna; Drutel, Robert; Leanhart, Silvia; Bogacz, Marek; Pacholczyk, Rafal.
Affiliation
  • Kern J; Center for Biotechnology and Genomic Medicine, Georgia Regents University, Augusta, Georgia, United States of America.
  • Drutel R; Center for Biotechnology and Genomic Medicine, Georgia Regents University, Augusta, Georgia, United States of America.
  • Leanhart S; Center for Biotechnology and Genomic Medicine, Georgia Regents University, Augusta, Georgia, United States of America.
  • Bogacz M; Center for Biotechnology and Genomic Medicine, Georgia Regents University, Augusta, Georgia, United States of America.
  • Pacholczyk R; Center for Biotechnology and Genomic Medicine, Georgia Regents University, Augusta, Georgia, United States of America.
PLoS One ; 9(11): e112467, 2014.
Article in En | MEDLINE | ID: mdl-25379761
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Receptors, Antigen, T-Cell / T-Lymphocytes / Sjogren's Syndrome / Diabetes Mellitus, Type 1 Type of study: Prognostic_studies Limits: Animals Language: En Year: 2014 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Receptors, Antigen, T-Cell / T-Lymphocytes / Sjogren's Syndrome / Diabetes Mellitus, Type 1 Type of study: Prognostic_studies Limits: Animals Language: En Year: 2014 Type: Article